ExLibris header image
SFX Logo
Title: A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes
Source:

Science [0036-8075] Rosenberg, S A yr:1986


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Rosenberg, Beverly A. "Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma." The New England journal of medicine 319.25 (1988): 1676-1680. Link to SFX for this item
2. Treisman, J. "Systemic therapy for cutaneous melanoma." Clinics in plastic surgery 37.1: 127-146. Link to SFX for this item
3. Rosenberg, S A A. "Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer." New England Journal of Medicine, The 313.23 (1986): 1485-92. Link to SFX for this item
4. Zou, W. "Regulatory T cells, tumour immunity and immunotherapy." Nature reviews. Immunology 6.4 (2006): 295-307. Link to Full Text for this item Link to SFX for this item
5. Lothe, Ragnhild A A. "Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses." Molecular cancer 6.1 (2007): 2-2. Link to Full Text for this item Link to SFX for this item
6. Dudley, Mark E E. "Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes." Science 298.5594 (2002): 850-4. Link to SFX for this item
7. Dudley, Mark E E. "Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma." Journal of clinical oncology 23.10 (2005): 2346-57. Link to SFX for this item
8. Rothstein, J L. "Tissue damage caused by TNF and complement." Immunology series (1992): 453-481. Link to SFX for this item
9. ROSENBERG, S. "TREATMENT OF PATIENTS WITH METASTATIC MELANOMA WITH AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2." Journal of the National Cancer Institute 86.15 (1994): 1159-1166. Link to Full Text for this item Link to SFX for this item
10. Morgan, Richard A. "Cancer regression in patients after transfer of genetically engineered lymphocytes." Science 314.5796 (2006): 126-9. Link to SFX for this item
11. Lifchez, Scott D. "Melanoma: workup and surveillance." Clinics in plastic surgery 37.1 (2010): 55-63. Link to SFX for this item
12. Stadelmann, Wayne K. "The role of lymphatic mapping and sentinel lymph node biopsy in the staging and treatment of melanoma." Clinics in plastic surgery 37.1 (2010): 79-99. Link to SFX for this item
13. Tsai, S. "Translational research in melanoma." Surgical oncology clinics of North America 22.4 (2008): 391-419. Link to SFX for this item
14. King, M. "Spontaneous Regression of Metastatic Malignant Melanoma of the Parotid Gland and Neck Lymph Nodes: a Case Report and a Review of the Literature." Clinical Oncology 13.6 (2001): 466-469. Link to Full Text for this item Link to SFX for this item
15. Peng, R. "Toll-Like Receptor 8-Mediated Reversal of CD4+ Regulatory T Cell Function." Science 309.5739 (2005): 1380-4. Link to SFX for this item
16. Komai-Koma, H. "Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells." Proceedings of the National Academy of Sciences of the United States of America 103.18 (2006): 7048-53. Link to Full Text for this item Link to SFX for this item
17. Rabinovich, Gabriel A A. "Immunosuppressive strategies that are mediated by tumor cells." Annual review of immunology 25.1 (2007): 267-96. Link to Full Text for this item Link to SFX for this item
18. Banchereau, J. "Dendritic cells as therapeutic vaccines against cancer." Nature reviews. Immunology 5.4 (2005): 296-306. Link to Full Text for this item Link to SFX for this item
19. Berger, L F. "T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years." Science 270.5235: 475-480. Link to SFX for this item
20. Auld, Ron F A. "Skp2-mediated p27(Kip1) degradation during S/G(2) phase progression of adipocyte hyperplasia." Journal of cellular physiology (2007): 101-11. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.